Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24, 2020. A news release will be issued at...
DUBLIN, Nov. 17, 2020 /PRNewswire/ -- Medtronic plc (NYSE:MDT) announced today that it will report financial results for its second quarter of fiscal year 2021 on Tuesday, November 24, 2020. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at http://newsroom.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2021, which ended on Friday, October 30, 2020.
Medtronic will host a webcast at 7:00 a.m. CST to discuss financial results for its second quarter of fiscal year 2021. The webcast can be accessed at http://investorrelations.medtronic.com on November 24, 2020.
Within 24 hours of the webcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at http://investorrelations.medtronic.com.
Looking ahead, Medtronic plans to report its fiscal year 2021 third and fourth quarter results on Tuesday, February 23, 2021, and Thursday, May 27, 2021, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
Medtronic plc (www.medtronic.com), headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 90,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
SOURCE Medtronic plc